Cargando…

Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database

None.

Detalles Bibliográficos
Autores principales:	Heaton, Joseph N., Singh, Sohrab, Li, Matthew, Vallabhajosyula, Saraschandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642653/ https://www.ncbi.nlm.nih.gov/pubmed/34699910 http://dx.doi.org/10.1016/j.ihj.2021.10.008

Ejemplares similares

Coronary Intra-orbital Atherectomy Complications and Procedural Failure: Insight From the Manufacturer and User Facility Device Experience (MAUDE) Database
por: Alhusain, Rashid, et al.
Publicado: (2023)

A Primer to the Structure, Content and Linkage of the FDA’s Manufacturer and User Facility Device Experience (MAUDE) Files
por: Ensign, Lisa Garnsey, et al.
Publicado: (2017)

Infectious complications in patients with ventricular assist device HeartMate II
por: Konarik, M, et al.
Publicado: (2013)

Recurrent Early Thrombus Formation in HeartMate II Left Ventricular Assist Device
por: Capoccia, Massimo, et al.
Publicado: (2013)

Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
por: Chang, Hsiao-Huang, et al.
Publicado: (2023)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation
por: Hosseini, Morteza Tavakkoli, et al.
Publicado: (2013)

Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation
por: van den Bergh, Walter M., et al.
Publicado: (2015)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
por: Imamura, Teruhiko, et al.
Publicado: (2020)

The Prevalence of Cardiovascular Complications and Causes of AngioJet Failure: A Post-Marketing Surveillance Study Based on the MAUDE (Manufacturer and User Facility Device Experience) Database
por: Dandu, Chaitu, et al.
Publicado: (2023)

Reporter’s occupation and source of adverse device event reports contained in the FDA’s MAUDE database
por: Kavanagh, Kevin T, et al.
Publicado: (2019)

Accuracy of Doppler blood pressure measurement in HeartMate 3 ventricular assist device patients
por: Li, Song, et al.
Publicado: (2020)

Initial Canadian Experience With Bilateral Minithoracotomy Approach for HeartMate 3 Left Ventricular Assist Device Implantation
por: Vasanthan, Vishnu, et al.
Publicado: (2019)

Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size
por: Tonai, Kohei, et al.
Publicado: (2022)

Long-Term Withdrawal of Anticoagulation and Antiplatelet Therapy in a HeartMate 3 Left Ventricular Assist Device
por: Menchaca, Kristina, et al.
Publicado: (2022)

Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation
por: Damman, Kevin, et al.
Publicado: (2022)

Inflow cannula position as risk factor for stroke in patients with HeartMate 3 left ventricular assist devices
por: Schlöglhofer, Thomas, et al.
Publicado: (2022)

Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib
por: Lotan, Dor, et al.
Publicado: (2022)

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
por: Balceniuk, Mark D., et al.
Publicado: (2020)

Evaluation of patients with a HeartMate 3 left ventricular assist device using echocardiographic particle image velocimetry
por: Schinkel, Arend F. L., et al.
Publicado: (2020)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
por: Numan, Lieke, et al.
Publicado: (2023)

Complications and device failures associated with urolift: Findings from the MAUDE database
por: Juliebø-Jones, Patrick, et al.
Publicado: (2023)

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device
por: Nguyen Thanh, Hien Kiem, et al.
Publicado: (2015)

Analysis Paralysis: Transition to HeartMate 3 Left Ventricular Assist Device Despite Multiple Complications from COVID-19
por: BhatiaPatel, S., et al.
Publicado: (2022)

Human Factors Evaluation of HeartMate 3 Left Ventricular Assist Device Peripherals: An Eye Tracking Supported Simulation Study
por: Widhalm, Gregor, et al.
Publicado: (2023)

Device malfunctions with use of EUS–guided fine-needle biopsy devices: Analysis of the MAUDE database
por: Singh, Achintya D., et al.
Publicado: (2023)

Clinical adverse events and device failures for the Barrx™ radiofrequency ablation catheter system: a MAUDE database analysis
por: Dubrouskaya, Katsiaryna, et al.
Publicado: (2022)

Commentary: Intraoperative cryoblation during HeartMate 3 left ventricular assist device implantation for refractory ventricular arrhythmias: Ipsa scientia potestas est
por: Altshuler, Peter J., et al.
Publicado: (2020)

High fidelity computational simulation of thrombus formation in Thoratec HeartMate II continuous flow ventricular assist device
por: Wu, Wei-Tao, et al.
Publicado: (2016)

Adverse events associated with AXIOS stents: Insights from the manufacturer and user facility device experience database
por: Ramai, Daryl, et al.
Publicado: (2022)

Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021)

Ruptured hemorrhagic bulla in a patient with a HeartMate 3 treated with an Amplatzer device
por: daSilva-deAbreu, Adrian, et al.
Publicado: (2021)

Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II
por: Akin, S., et al.
Publicado: (2015)

Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
por: Elasfar, Abdelfatah, et al.
Publicado: (2018)

Use of HeartMate 3 ventricular assist device in second redo sternotomy for congenitally corrected transposition of the great arteries with dextrocardia and situs solitus
por: Knop, Gustavo L., et al.
Publicado: (2022)

Thoracic Endovascular Aortic Repair Adverse Events Reported In The Food And Drug Administration Manufacturer And User Facility Device Experience Database
por: Mansukhani, Neel A, et al.
Publicado: (2019)

Adverse Events Associated With Synthetic Male Slings: An Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database
por: Zhao, Hanson, et al.
Publicado: (2021)

Is flow really continuous in last generation continuous flow Ventricular Assist Devices? A comparison between HeartMate II and HeartWare HVAD
por: Melisurgo, G, et al.
Publicado: (2012)

Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tu9j62u8gtro32n0bg8i4ve4tf